期刊
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE
卷 161, 期 4, 页码 501-504出版社
SPRINGER
DOI: 10.1007/s10517-016-3447-6
关键词
type 2 diabetes mellitus; diabetic nephropathy; linagliptin
资金
- Ministry of Education and Science of Russian Federation [RFME-FI62114X0010, RFMEFI61914X0005]
Effect of the dipeptidyl peptidase-4 inhibitor linagliptin on structural manifestations of diabetic nephropathy was studied in BKS.Cg-Dock7m+/+Leprdb/J mice (experimental model of type 2 diabetes mellitus). Linagliptin (10 mg/kg per day) or vehicle was administered by gavage over 8 weeks. Mesangial expansion, thickening of the basement membrane in glomerular capillaries and proximal tubules, and retraction of cytopodia were less pronounced in mice receiving linagliptin. The protective effect of linagliptin on the kidney structure was not associated with its hypoglycemic action.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据